UK/ICLG/P/22/0103
ES/ICLG/M/21/0006

This promotional meeting has been funded and organised by Incyte. This event is for UK and EU healthcare professionals only and will involve discussion of Incyte products. Always refer to the latest version of the product label in your country. All adverse events should be reported to the Global Medical Information Call Centre by phone: +800 000 27423 (for local numbers see www.incyteglobalmedicalinformation.com/report-adverse-event.aspx (incyteglobalmedicalinformation.com)). Alternatively, you can report AEs by email: eumedinfo@incyte.com. For more information, please contact Incyte Medical Information: eumedinfo@incyte.com. The ICLUSIG (ponatinib) SmPC is available here (https://www.ema.europa.eu/en/medicines/human/EPAR/iclusig). 

© 2022, Incyte. All rights reserved.
Date of preparation: August 2022